fda pulling semaglutide is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Compound versions of GLP-1 drugs

Here are proactive steps you can implement: Maintain an Updated Medication List: Keep a comprehensive and current list of all your medications, including prescription drugs, over-the-counter remedies, vitamins, and herbal supplements

Preclinical studies also indicate that tanycytes, specialized glial cells within the CNS, may facilitate the transportation of peripheral GLP-1RAs, such as semaglutide, into the CNS, bypassing the blood-brain barrier to access appetite-regulating hypothalamic regions such as the arcuate nucleus (60, 61)

In people living with Type 2 diabetes, plasma and urine levels of Hpa are increased [39, 40]

Those who relied primarily on the medication without lifestyle modifications face higher risks of regaining weight